^
    1year
    Detection of tumor-associated methylation and mutation signatures for early colorectal cancer diagnosis (AACR 2023)
    We have developed and validated the targeted NGS-based panels to detect clinically relevant mutation and methylation patterns and demonstrate its potential as a highly sensitive assay for early CRC diagnosis.
    OptiSeq™ Colorectal Cancer Panel